Simplex Trading’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-3,042
| Closed | -$532K | – | 9614 |
|
|
2025
Q4 | $517K | Buy |
3,042
+2,151
| +241% | +$330K | ﹤0.01% | 3276 |
|
|
2025
Q3 | $117K | Buy |
891
+537
| +152% | +$64.4K | ﹤0.01% | 5559 |
|
|
2025
Q2 | $37K | Sell |
354
-3,417
| -91% | -$371K | ﹤0.01% | 6210 |
|
|
2025
Q1 | $468K | Buy |
3,771
+3,524
| +1,427% | +$460K | ﹤0.01% | 3462 |
|
|
2024
Q4 | $30K | Sell |
247
-1,824
| -88% | -$215K | ﹤0.01% | 6356 |
|
|
2024
Q3 | $230K | Sell |
2,071
-1,522
| -42% | -$167K | ﹤0.01% | 4394 |
|
|
2024
Q2 | $383K | Buy |
+3,593
| New | +$395K | ﹤0.01% | 3941 |
|
|
2023
Q3 | – | Sell |
-56
| Closed | -$7.46K | – | 9220 |
|
|
2023
Q2 | $6K | Buy |
+56
| New | +$7.54K | ﹤0.01% | 7796 |
|
|
2022
Q4 | – | Sell |
-9,807
| Closed | -$1.44M | – | 9780 |
|
|
2022
Q3 | $1.31M | Buy |
9,807
+3,955
| +68% | +$601K | ﹤0.01% | 2355 |
|
|
2022
Q2 | $912K | Sell |
5,852
-10,848
| -65% | -$1.67M | ﹤0.01% | 2725 |
|
|
2022
Q1 | $2.6M | Buy |
+16,700
| New | +$2.42M | ﹤0.01% | 1836 |
|
|
2021
Q3 | – | Sell |
-177
| Closed | -$26.7K | – | 9815 |
|
|
2021
Q2 | $31K | Buy |
+177
| New | +$30.7K | ﹤0.01% | 8200 |
|
|
2021
Q1 | – | Sell |
-1,367
| Closed | -$225K | – | 9379 |
|
|
2020
Q4 | $225K | Sell |
1,367
-13,810
| -91% | -$2.06M | ﹤0.01% | 4451 |
|
|
2020
Q3 | $2.16M | Buy |
15,177
+14,891
| +5,207% | +$1.85M | ﹤0.01% | 1466 |
|
|
2020
Q2 | $31K | Buy |
+286
| New | +$31.6K | ﹤0.01% | 5893 |
|
|
2019
Q1 | – | Sell |
-640
| Closed | -$83.5K | – | 7457 |
|
|
2018
Q4 | $79K | Buy |
+640
| New | +$94.9K | ﹤0.01% | 4078 |
|
|
2018
Q2 | – | Sell |
-1,544
| Closed | -$252K | – | 7619 |
|
|
2018
Q1 | $233K | Sell |
1,544
-1,449
| -48% | -$213K | 0.01% | 1143 |
|
|
2017
Q4 | $403K | Buy |
2,993
+2,320
| +345% | +$322K | 0.02% | 830 |
|
|
2017
Q3 | $98K | Buy |
+673
| New | +$102K | ﹤0.01% | 1725 |
|
|
2017
Q2 | – | Sell |
-8,470
| Closed | -$1.3M | – | 6439 |
|
|
2017
Q1 | $1.23M | Buy |
+8,470
| New | +$1.1M | 0.05% | 320 |
|
|
2016
Q1 | – | Sell |
-273
| Closed | -$34K | – | 5901 |
|
|
2015
Q4 | $38K | Sell |
273
-4,621
| -94% | -$640K | ﹤0.01% | 2141 |
|
|
2015
Q3 | $649K | Buy |
4,894
+4,594
| +1,531% | +$791K | 0.05% | 353 |
|
|
2015
Q2 | $52K | Sell |
300
-2,156
| -88% | -$387K | ﹤0.01% | 1663 |
|
|
2015
Q1 | $424K | Buy |
2,456
+2,335
| +1,930% | +$401K | 0.05% | 377 |
|
|
2014
Q4 | $20K | Buy |
+121
| New | +$20.1K | ﹤0.01% | 2054 |
|
Other funds holding JAZZ
VPM
VCM
EC
Simplex Trading's JAZZ Position: Q1 2026 in Review
Simplex Trading sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2026, closing a stake of 3,042 shares — an estimated $532K sold.
Simplex Trading first reported a position in JAZZ in Q4 2014 and held it in 25 quarters. The position peaked at $2.6M in Q1 2022. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- Simplex Trading reported no remaining Jazz Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
- Simplex Trading sold 3,042 Jazz Pharmaceuticals shares in Q1 2026, an estimated $532K.
- Simplex Trading first reported a position in Jazz Pharmaceuticals in Q4 2014 and held it in 25 quarters.
- Simplex Trading's Jazz Pharmaceuticals position peaked at $2.6M in Q1 2022.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.